Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital
<b>Background/Objectives</b>: Tuberculosis (TB) is preventable and curable, but multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) pose significant challenges worldwide due to the limited treatment options, lengths of therapies, and high rates of treatment failure...
Saved in:
Main Authors: | Gina Gualano, Maria Musso, Paola Mencarini, Silvia Mosti, Carlotta Cerva, Pietro Vittozzi, Antonio Mazzarelli, Angela Cannas, Assunta Navarra, Stefania Ianniello, Paolo Faccendini, Fabrizio Palmieri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/1/7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Savings from the introduction of BPaL and BPaLM regimens at the country level
by: C. Auer, et al.
Published: (2024-07-01) -
Buffalo milk quality in southern Italy: trace elements & endocrine disruptors. A One Health analysis
by: Luigi Jacopo D’Auria
Published: (2023-11-01) -
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan
by: M.A. Khan, et al.
Published: (2024-11-01) -
Comprehensive Analysis of the Proteome of <i>S. cerevisiae</i> Wild-Type and <i>pdr</i>5Δ Cells in Response to Bisphenol A (BPA) Exposure
by: Valentina Rossio, et al.
Published: (2025-01-01) -
Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01)